These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 36972188)
1. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway. Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188 [TBL] [Abstract][Full Text] [Related]
2. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
4. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway. Huang S; Zhao H; Lou X; Chen D; Shi C; Ren Z Biochem Biophys Res Commun; 2024 Jul; 718():149983. PubMed ID: 38718735 [TBL] [Abstract][Full Text] [Related]
5. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2. Li Z; Zhao PL; Gao X; Li X; Meng YQ; Li ZQ; Zhai KR; Wei SL; Feng HM; Huang HR; Li B Int Immunopharmacol; 2024 Dec; 142(Pt A):113043. PubMed ID: 39216120 [TBL] [Abstract][Full Text] [Related]
6. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway. Zheng Y; You H; Duan J; Chen B; Wu C; Chen P; Wang M Genes Genomics; 2022 Sep; 44(9):1039-1049. PubMed ID: 35150399 [TBL] [Abstract][Full Text] [Related]
7. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
8. PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25. Zhang W; Yu L; Xu C; Tang T; Cao J; Chen L; Pang X; Ren W Cell Biol Int; 2024 Sep; 48(9):1285-1300. PubMed ID: 38894536 [TBL] [Abstract][Full Text] [Related]
9. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling. Liu Z; Hu Z; Cai X; Liu S Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway. Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma. Xue F; Jia Y; Zhao J Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075 [TBL] [Abstract][Full Text] [Related]
12. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338 [TBL] [Abstract][Full Text] [Related]
13. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma. Wu Q; Wang YB; Che XW; Wang H; Wang W J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006 [TBL] [Abstract][Full Text] [Related]
15. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway. Zhu HE; Yin JY; Chen DX; He S; Chen H Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997 [TBL] [Abstract][Full Text] [Related]
16. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma. Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764 [TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma. Wang Y; Mei X; Song W; Wang C; Qiu X BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617 [TBL] [Abstract][Full Text] [Related]
18. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway. Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987 [TBL] [Abstract][Full Text] [Related]
19. The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway. Qian S; Wang F; Liao W; Liu J Neoplasma; 2024 Feb; 71(1):22-36. PubMed ID: 38506034 [TBL] [Abstract][Full Text] [Related]
20. NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m Du X; Cheng C; Yang Y; Fan B; Wang P; Xia H; Ni X; Liu Q; Lu L; Wei L Mol Carcinog; 2024 May; 63(5):962-976. PubMed ID: 38411298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]